UPDATED Jun 14, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMA | ৳200.00 | -1.7% | -4.7% | ৳177.3b | ৳328.00 | PE8.8x | E12.2% | 5.3% | ||
BXPHARMA | ৳105.10 | -1.6% | -28.1% | ৳46.9b | ৳177.50 | PE8.8x | E15.6% | 3.3% |